首页 > 最新文献

Asian journal of andrology最新文献

英文 中文
Compound heterozygous variants of the DMRTC2 gene are associated with non-obstructive azoospermia in a patient. DMRTC2基因的复合杂合变异与患者的非阻塞性无精子症有关。
IF 2.7 Pub Date : 2025-11-11 DOI: 10.4103/aja202573
Xian-You Gan, Yue Meng, Xiao-Bin Ling, Lan-Xi Ran, Man Yang, Teng-Yan Li, Yan Sun, Bin-Bin Wang
{"title":"Compound heterozygous variants of the DMRTC2 gene are associated with non-obstructive azoospermia in a patient.","authors":"Xian-You Gan, Yue Meng, Xiao-Bin Ling, Lan-Xi Ran, Man Yang, Teng-Yan Li, Yan Sun, Bin-Bin Wang","doi":"10.4103/aja202573","DOIUrl":"https://doi.org/10.4103/aja202573","url":null,"abstract":"","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel biallelic DNHD1 variants associated with male infertility with severe MMAF phenotype. 新型双等位基因DNHD1变异与严重MMAF表型的男性不育症相关。
IF 2.7 Pub Date : 2025-11-11 DOI: 10.4103/aja202535
Islam Uddin, Iqra Zafar, Cao-Ling Xu, Xue-Mei Xing, Wen-Qing Li, Jia-Qi Zou, Hossein Tahmasebi, Muhammad Imran Khan, Li-Min Wu, Jian-Qiang Bao

Abstract: Multiple morphological abnormalities of the sperm flagella (MMAF), characterized by severe morphological sperm defects, such as absent, short, irregular caliber, and coiled flagella with extreme asthenoteratozoospermia, are the most prevalent cause of human male infertility. Previous studies have identified several genes linked to MMAF; however, the increasing incidence of infertility indicates that most affected individuals remain undiagnosed, prompting further investigation to uncover novel mutations and genes. Whole-exome sequencing (WES) was conducted on a consanguineous infertile family from Pakistan to investigate the potential monogenic inheritance pattern in individuals affected by asthenoteratozoospermia. WES identified novel homozygous variants (c.A4457G; p.K1486R, and c.C10624T; p.R3542*) in dynein heavy chain domain 1 (DNHD1) in the proband and his affected brother. Semen analysis revealed a low progressive motility and severe MMAF in both siblings. Hematoxylin and eosin staining, immunofluorescence, and transmission electron microscopy unveiled an abnormal axoneme structure characterized by missing central pairs, disorganized microtubule duplets, and severe mitochondrial sheath defects, which led to the low sperm progressive motility and infertility in the affected siblings. This study identified a novel biallelic nonsense variant in DNHD1 that caused MMAF in a Pakistani population, endorsing previous findings and expanding the spectrum of potential DNHD1 variants in the pathogenesis of asthenoteratozoospermia.

摘要精子鞭毛的多重形态异常(MMAF)是人类男性不育最常见的原因,其特征是鞭毛缺失、短、直径不规则、卷曲等严重的精子形态缺陷,并伴有极度的弱异精子症。先前的研究已经确定了几个与MMAF相关的基因;然而,不孕症发病率的增加表明,大多数受影响的个体仍未被诊断出来,这促使进一步的研究发现新的突变和基因。对来自巴基斯坦的一个近亲不育家庭进行了全外显子组测序(WES),以研究弱异卵精子症患者潜在的单基因遗传模式。WES在先证者及其患病兄弟的动力蛋白重链结构域1 (DNHD1)中发现了新的纯合变异体(c.A4457G; p.K1486R, c.C10624T; p.R3542*)。精液分析显示两兄弟均有低进行性运动和严重的MMAF。苏木精和伊红染色、免疫荧光和透射电镜显示轴突结构异常,其特征是中心对缺失、微管双胞胎紊乱、线粒体鞘严重缺陷,导致受影响的兄弟姐妹精子进行性运动能力低和不育。本研究在巴基斯坦人群中发现了一种新的DNHD1双等位无意义变异,该变异导致了MMAF,支持了先前的发现,并扩大了DNHD1在弱异性精子症发病机制中的潜在变异谱。
{"title":"Novel biallelic DNHD1 variants associated with male infertility with severe MMAF phenotype.","authors":"Islam Uddin, Iqra Zafar, Cao-Ling Xu, Xue-Mei Xing, Wen-Qing Li, Jia-Qi Zou, Hossein Tahmasebi, Muhammad Imran Khan, Li-Min Wu, Jian-Qiang Bao","doi":"10.4103/aja202535","DOIUrl":"https://doi.org/10.4103/aja202535","url":null,"abstract":"<p><strong>Abstract: </strong>Multiple morphological abnormalities of the sperm flagella (MMAF), characterized by severe morphological sperm defects, such as absent, short, irregular caliber, and coiled flagella with extreme asthenoteratozoospermia, are the most prevalent cause of human male infertility. Previous studies have identified several genes linked to MMAF; however, the increasing incidence of infertility indicates that most affected individuals remain undiagnosed, prompting further investigation to uncover novel mutations and genes. Whole-exome sequencing (WES) was conducted on a consanguineous infertile family from Pakistan to investigate the potential monogenic inheritance pattern in individuals affected by asthenoteratozoospermia. WES identified novel homozygous variants (c.A4457G; p.K1486R, and c.C10624T; p.R3542*) in dynein heavy chain domain 1 (DNHD1) in the proband and his affected brother. Semen analysis revealed a low progressive motility and severe MMAF in both siblings. Hematoxylin and eosin staining, immunofluorescence, and transmission electron microscopy unveiled an abnormal axoneme structure characterized by missing central pairs, disorganized microtubule duplets, and severe mitochondrial sheath defects, which led to the low sperm progressive motility and infertility in the affected siblings. This study identified a novel biallelic nonsense variant in DNHD1 that caused MMAF in a Pakistani population, endorsing previous findings and expanding the spectrum of potential DNHD1 variants in the pathogenesis of asthenoteratozoospermia.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial comment on "Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil". 关于胶原酶溶组织梭菌、真空勃起装置和他达拉非联合治疗Peyronie病的结局和治疗的评论。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-05-13 DOI: 10.4103/aja202533
Martin K Gelbard
{"title":"Editorial comment on \"Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil\".","authors":"Martin K Gelbard","doi":"10.4103/aja202533","DOIUrl":"10.4103/aja202533","url":null,"abstract":"","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"763"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil. 胶原酶溶组织梭菌、真空勃起装置和他达拉非联合治疗Peyronie病的疗效和治疗
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-05-02 DOI: 10.4103/aja202514
Raidh Talib Alzubaidi, Mohamed Abdelkareem, Raed M Al-Zoubi, Ahmad R Al-Qudimat, Aksam Yasin, Hatem Kamkoum, Abdullah A Al-Ansari

Abstract: Peyronie's disease (PD) is a connective tissue disorder characterized by abnormal collagen deposition in the tunica albuginea, leading to penile curvature, pain, and erectile dysfunction. This study aimed to evaluate the outcomes of a combined treatment protocol incorporating collagenase clostridium histolyticum (CCH), vacuum erection device, and tadalafil. A retrospective analysis was conducted on 99 male patients with PD treated at the Department of Urology, Hamad Medical Corporation (Doha, Qatar) between January 2018 and January 2020. Patients received 4-8 CCH injections alongside vacuum therapy and daily tadalafil (5 mg). The baseline mean penile curvature of 49.0° improved by an average of 21.4% post-treatment. Erectile function scores also increased significantly, with a mean improvement of 2.3 points on the International Index of Erectile Function. Minor complications were observed in 15 patients, while 13 were dissatisfied with treatment, with six opting for surgery. The modified protocol demonstrated significant improvements in penile curvature and erectile function with minimal complications, offering a safe, cost-effective alternative to traditional intensive treatments.

摘要:佩罗尼氏病(PD)是一种结缔组织疾病,其特征是白膜胶原沉积异常,导致阴茎弯曲、疼痛和勃起功能障碍。本研究旨在评估胶原酶溶组织梭菌(CCH)、真空勃起装置和他达拉非联合治疗方案的结果。回顾性分析2018年1月至2020年1月在哈马德医疗公司(卡塔尔多哈)泌尿外科治疗的99例男性PD患者。患者在真空治疗和每日他达拉非(5mg)的同时接受4-8次CCH注射。基线平均阴茎弯曲度为49.0°,治疗后平均改善21.4%。勃起功能评分也显著提高,国际勃起功能指数平均提高2.3分。15例出现轻微并发症,13例对治疗不满意,6例选择手术治疗。改进后的方案在阴茎弯曲度和勃起功能方面有显著改善,并发症最少,提供了传统强化治疗的安全、经济的替代方案。
{"title":"Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil.","authors":"Raidh Talib Alzubaidi, Mohamed Abdelkareem, Raed M Al-Zoubi, Ahmad R Al-Qudimat, Aksam Yasin, Hatem Kamkoum, Abdullah A Al-Ansari","doi":"10.4103/aja202514","DOIUrl":"10.4103/aja202514","url":null,"abstract":"<p><strong>Abstract: </strong>Peyronie's disease (PD) is a connective tissue disorder characterized by abnormal collagen deposition in the tunica albuginea, leading to penile curvature, pain, and erectile dysfunction. This study aimed to evaluate the outcomes of a combined treatment protocol incorporating collagenase clostridium histolyticum (CCH), vacuum erection device, and tadalafil. A retrospective analysis was conducted on 99 male patients with PD treated at the Department of Urology, Hamad Medical Corporation (Doha, Qatar) between January 2018 and January 2020. Patients received 4-8 CCH injections alongside vacuum therapy and daily tadalafil (5 mg). The baseline mean penile curvature of 49.0° improved by an average of 21.4% post-treatment. Erectile function scores also increased significantly, with a mean improvement of 2.3 points on the International Index of Erectile Function. Minor complications were observed in 15 patients, while 13 were dissatisfied with treatment, with six opting for surgery. The modified protocol demonstrated significant improvements in penile curvature and erectile function with minimal complications, offering a safe, cost-effective alternative to traditional intensive treatments.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"686-690"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exogenous administration of heparin-binding epidermal growth factor-like growth factor improves erectile function in mice with bilateral cavernous nerve injury. 外源性肝素结合表皮生长因子样生长因子可改善双侧海绵状神经损伤小鼠的勃起功能。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-04-18 DOI: 10.4103/aja2024125
Minh Nhat Vo, Mi-Hye Kwon, Fang-Yuan Liu, Fitri Rahma Fridayana, Yan Huang, Soon-Sun Hong, Ju-Hee Kang, Guo Nan Yin, Ji-Kan Ryu

Abstract: Prostate cancer is the second most common malignancy and the sixth leading cause of cancer-related death in men worldwide. Radical prostatectomy (RP) is the standard treatment for localized prostate cancer, but the procedure often results in postoperative erectile dysfunction (ED). The poor efficacy of phosphodiesterase 5 inhibitors after surgery highlights the need to develop new therapies to enhance cavernous nerve regeneration and improve the erectile function of these patients. In the present study, we aimed to examine the potential of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in preserving erectile function in cavernous nerve injury (CNI) mice. We found that HB-EGF expression was reduced significantly on the 1 st day after CNI in penile tissue. Ex vivo and in vitro studies showed that HB-EGF promotes major pelvic ganglion neurite sprouting and neuro-2a (N2a) cell migration. In vivo studies showed that exogenous HB-EGF treatment significantly restored the erectile function of CNI mice to 86.9% of sham levels. Immunofluorescence staining showed that mural and neuronal cells were preserved by inducing cell proliferation and reducing apoptosis and reactive oxygen species production. Western blot analysis showed that HB-EGF upregulated protein kinase B and extracellular signal-regulated kinase activation and neurotrophic factor expression. Overall, HB-EGF is a major promising therapeutic agent for treating ED in postoperative RP.

前列腺癌是全球第二大常见恶性肿瘤,也是男性癌症相关死亡的第六大原因。根治性前列腺切除术(RP)是局部前列腺癌的标准治疗方法,但该手术通常会导致术后勃起功能障碍(ED)。磷酸二酯酶5抑制剂术后疗效不佳,因此需要开发新的治疗方法来促进海绵体神经再生,改善这些患者的勃起功能。在本研究中,我们旨在研究肝素结合表皮生长因子样生长因子(HB-EGF)在海绵状神经损伤(CNI)小鼠中保护勃起功能的潜力。我们发现,在CNI后第1天,HB-EGF在阴茎组织中的表达明显降低。离体和体外研究表明,HB-EGF促进盆腔神经节主要神经突的发芽和神经2a (N2a)细胞的迁移。体内研究表明,外源性HB-EGF处理可使CNI小鼠的勃起功能显著恢复到假手术水平的86.9%。免疫荧光染色显示,通过诱导细胞增殖、减少细胞凋亡和活性氧的产生,壁画细胞和神经元细胞得以保存。Western blot分析显示HB-EGF上调蛋白激酶B和细胞外信号调节激酶活化和神经营养因子表达。总体而言,HB-EGF是治疗RP术后ED的主要有前景的治疗药物。
{"title":"Exogenous administration of heparin-binding epidermal growth factor-like growth factor improves erectile function in mice with bilateral cavernous nerve injury.","authors":"Minh Nhat Vo, Mi-Hye Kwon, Fang-Yuan Liu, Fitri Rahma Fridayana, Yan Huang, Soon-Sun Hong, Ju-Hee Kang, Guo Nan Yin, Ji-Kan Ryu","doi":"10.4103/aja2024125","DOIUrl":"10.4103/aja2024125","url":null,"abstract":"<p><strong>Abstract: </strong>Prostate cancer is the second most common malignancy and the sixth leading cause of cancer-related death in men worldwide. Radical prostatectomy (RP) is the standard treatment for localized prostate cancer, but the procedure often results in postoperative erectile dysfunction (ED). The poor efficacy of phosphodiesterase 5 inhibitors after surgery highlights the need to develop new therapies to enhance cavernous nerve regeneration and improve the erectile function of these patients. In the present study, we aimed to examine the potential of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in preserving erectile function in cavernous nerve injury (CNI) mice. We found that HB-EGF expression was reduced significantly on the 1 st day after CNI in penile tissue. Ex vivo and in vitro studies showed that HB-EGF promotes major pelvic ganglion neurite sprouting and neuro-2a (N2a) cell migration. In vivo studies showed that exogenous HB-EGF treatment significantly restored the erectile function of CNI mice to 86.9% of sham levels. Immunofluorescence staining showed that mural and neuronal cells were preserved by inducing cell proliferation and reducing apoptosis and reactive oxygen species production. Western blot analysis showed that HB-EGF upregulated protein kinase B and extracellular signal-regulated kinase activation and neurotrophic factor expression. Overall, HB-EGF is a major promising therapeutic agent for treating ED in postoperative RP.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"697-706"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel frameshift variant in AXDND1 may cause multiple morphological abnormalities of the sperm flagella in a consanguineous Pakistani family. 一种新的移码变异的AXDND1可能导致精子鞭毛的多种形态异常在一个近亲巴基斯坦家庭。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-06-03 DOI: 10.4103/aja202538
Imtiaz Ali, Meng-Lei Yang, Fazal Rahim, Haider Ali, Aurang Zeb, Nisar Ahmad, Yousaf Raza, Wang Yue, Muhammad Shoaib, Tanveer Abbas, Wasim Shah, Hui Ma, Huan Zhang, Hao Yin, Qing-Hua Shi

Abstract: The syndrome of multiple morphological abnormalities of the sperm flagella (MMAF) is one of the most serious kinds of sperm defects, leading to asthenoteratozoospermia and male infertility. In this study, we use whole-exome sequencing to identify genetic factors that account for male infertility in a patient born from a consanguineous Pakistani couple. A homozygous frameshift mutation (c.1399_1402del; p.Gln468ArgfsTer2) in axonemal dynein light chain domain containing 1 ( AXDND1 ) was identified in the patient. Sanger sequencing data showed that the mutation was cosegregated recessively with male infertility in this family. Papanicolaou staining and scanning electron microscopy analysis of the sperm revealed severely abnormal flagellar morphology in the patient. Immunofluorescence and western blot showed undetectable AXDND1 expression in the sperm of the patient. Transmission electron microscopy analysis showed disorganized sperm axonemal structure in the patient, particularly missing the central pair of microtubules. Immunofluorescence staining showed the absence of sperm-associated antigen 6 (SPAG6) and dynein axonemal light intermediate chain 1 (DNALI1) signals in the sperm flagella of the patient. These findings indicate that AXDND1 is essential for the organization of flagellar axoneme and provide direct evidence that AXDND1 is a MMAF gene in humans, thus expanding the phenotypic spectrum of AXDND1 frameshift mutations.

精子鞭毛多重形态异常综合征(MMAF)是精子缺陷中最严重的一种,可导致弱异精子症和男性不育。在这项研究中,我们使用全外显子组测序来确定导致巴基斯坦一对近亲夫妇所生的男性不育患者的遗传因素。纯合移码突变(c. 1399_142del;在患者体内发现轴突动力蛋白轻链结构域1 (AXDND1) p.Gln468ArgfsTer2。Sanger测序数据显示该突变与该家族男性不育共分离隐性。精子的Papanicolaou染色和扫描电镜分析显示患者鞭毛形态严重异常。免疫荧光和western blot显示患者精子中未检测到AXDND1的表达。透射电镜分析显示患者精子轴突结构紊乱,特别是缺少中央一对微管。免疫荧光染色显示患者精子鞭毛中缺乏精子相关抗原6 (SPAG6)和动力蛋白轴突轻中间链1 (DNALI1)信号。这些发现表明,AXDND1对鞭毛轴突的组织至关重要,并提供了AXDND1是人类MMAF基因的直接证据,从而扩大了AXDND1移码突变的表型谱。
{"title":"A novel frameshift variant in AXDND1 may cause multiple morphological abnormalities of the sperm flagella in a consanguineous Pakistani family.","authors":"Imtiaz Ali, Meng-Lei Yang, Fazal Rahim, Haider Ali, Aurang Zeb, Nisar Ahmad, Yousaf Raza, Wang Yue, Muhammad Shoaib, Tanveer Abbas, Wasim Shah, Hui Ma, Huan Zhang, Hao Yin, Qing-Hua Shi","doi":"10.4103/aja202538","DOIUrl":"10.4103/aja202538","url":null,"abstract":"<p><strong>Abstract: </strong>The syndrome of multiple morphological abnormalities of the sperm flagella (MMAF) is one of the most serious kinds of sperm defects, leading to asthenoteratozoospermia and male infertility. In this study, we use whole-exome sequencing to identify genetic factors that account for male infertility in a patient born from a consanguineous Pakistani couple. A homozygous frameshift mutation (c.1399_1402del; p.Gln468ArgfsTer2) in axonemal dynein light chain domain containing 1 ( AXDND1 ) was identified in the patient. Sanger sequencing data showed that the mutation was cosegregated recessively with male infertility in this family. Papanicolaou staining and scanning electron microscopy analysis of the sperm revealed severely abnormal flagellar morphology in the patient. Immunofluorescence and western blot showed undetectable AXDND1 expression in the sperm of the patient. Transmission electron microscopy analysis showed disorganized sperm axonemal structure in the patient, particularly missing the central pair of microtubules. Immunofluorescence staining showed the absence of sperm-associated antigen 6 (SPAG6) and dynein axonemal light intermediate chain 1 (DNALI1) signals in the sperm flagella of the patient. These findings indicate that AXDND1 is essential for the organization of flagellar axoneme and provide direct evidence that AXDND1 is a MMAF gene in humans, thus expanding the phenotypic spectrum of AXDND1 frameshift mutations.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"691-696"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144210467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-intensity pulsed ultrasound treatment in erectile dysfunction. 低强度脉冲超声治疗勃起功能障碍。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-06-03 DOI: 10.4103/aja202518
Shi-Yun Liu, Si-Yu Liu, Bang-Min Han, Shu-Jie Xia

Abstract: Low-intensity pulsed ultrasound (LIPUS) is a non-invasive sonodynamic therapy that has been approved by the U.S. Food and Drug Administration for clinical use. Clinical trials have demonstrated that LIPUS ameliorates mild-to-moderate erectile dysfunction without adverse events. Histological analysis of the corpus cavernosum suggests that the therapeutic benefits of LIPUS may be attributed to alleviation of fibrosis, enhanced neovascularization, and promotion of innervation. Further investigations have revealed that LIPUS facilitates cavernous tissue repair through non-thermal mechanisms, including a cavitation effect, acoustic streaming, mass transfer enhancement, and direct mechanical stimulation. Mechanobiological transduction triggers molecular signaling cascades within endogenous cavernous cells, thereby stimulating cell proliferation, angiogenesis, extracellular matrix remodeling, and stem cell differentiation. Although LIPUS has the potential to induce cavernous rehabilitation in the treatment of erectile dysfunction, further investigations are necessary to elucidate the mechanisms via which LIPUS regulates each type of cavernous cell to determine the optimal parameters for this innovative therapy.

低强度脉冲超声(LIPUS)是一种非侵入性声动力疗法,已被美国食品和药物管理局批准用于临床。临床试验表明,LIPUS改善轻度至中度勃起功能障碍无不良事件。海绵体的组织学分析表明,LIPUS的治疗益处可能归因于减轻纤维化,增强新生血管和促进神经支配。进一步的研究表明,LIPUS通过非热机制促进海绵状组织修复,包括空化效应、声流、传质增强和直接机械刺激。机械生物学转导触发内源性海绵状细胞内的分子信号级联,从而刺激细胞增殖、血管生成、细胞外基质重塑和干细胞分化。虽然LIPUS在治疗勃起功能障碍时具有诱导海绵体康复的潜力,但需要进一步的研究来阐明LIPUS调节每种海绵体细胞的机制,以确定这种创新疗法的最佳参数。
{"title":"Low-intensity pulsed ultrasound treatment in erectile dysfunction.","authors":"Shi-Yun Liu, Si-Yu Liu, Bang-Min Han, Shu-Jie Xia","doi":"10.4103/aja202518","DOIUrl":"10.4103/aja202518","url":null,"abstract":"<p><strong>Abstract: </strong>Low-intensity pulsed ultrasound (LIPUS) is a non-invasive sonodynamic therapy that has been approved by the U.S. Food and Drug Administration for clinical use. Clinical trials have demonstrated that LIPUS ameliorates mild-to-moderate erectile dysfunction without adverse events. Histological analysis of the corpus cavernosum suggests that the therapeutic benefits of LIPUS may be attributed to alleviation of fibrosis, enhanced neovascularization, and promotion of innervation. Further investigations have revealed that LIPUS facilitates cavernous tissue repair through non-thermal mechanisms, including a cavitation effect, acoustic streaming, mass transfer enhancement, and direct mechanical stimulation. Mechanobiological transduction triggers molecular signaling cascades within endogenous cavernous cells, thereby stimulating cell proliferation, angiogenesis, extracellular matrix remodeling, and stem cell differentiation. Although LIPUS has the potential to induce cavernous rehabilitation in the treatment of erectile dysfunction, further investigations are necessary to elucidate the mechanisms via which LIPUS regulates each type of cavernous cell to determine the optimal parameters for this innovative therapy.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"673-679"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144210468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should couples with a low total progressively motile sperm count in the first intrauterine insemination cycle continue this treatment? 在第一个宫内人工授精周期中精子总数较低的夫妇是否应该继续这种治疗?
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-06-13 DOI: 10.4103/aja202524
Zheng Wang, Yuan-Yuan Wang, Shuo Huang, Hai-Yan Wang, Rong Li, Ben Willem Mol, Jie Qiao

Abstract: This study aimed to investigate the associations between the post-wash total progressively motile sperm count (TPMSC) in the first intrauterine insemination (IUI) cycle and pregnancy outcomes of the second IUI cycle. Data were retrieved from the clinical database at the Reproductive Center of Peking University Third Hospital (Beijing, China) between January 2011 and December 2022. Couples were included in this retrospective cohort study if they had unexplained or mild male factor infertility and were treated with IUI for two consecutive cycles using the same protocol. A total of 8290 couples were included in the analysis. The mean ± standard deviation (s.d.) age of women was 32.0 ± 3.5 years. We categorized groups based on the post-wash TPMSC (×10 6 ) levels in the first IUI cycle: group 1 (0 < TPMSC < 1, n = 1290), group 2 (1 ≤ TPMSC < 2, n = 863), group 3 (2 ≤ TPMSC < 3, n = 800), group 4 (3 ≤ TPMSC < 4, n = 783), group 5 (4 ≤ TPMSC < 5, n = 1541), group 6 (5 ≤ TPMSC < 6, n = 522), group 7 (6 ≤ TPMSC < 7, n = 547), group 8 (7 ≤ TPMSC < 8, n = 175), group 9 (8 ≤ TPMSC < 9, n = 556), group 10 (9 ≤ TPMSC < 10, n = 192), and group 11 (TPMSC ≥ 10), n = 1021). The primary outcome was live birth rate of the second IUI cycle. Live birth rates were 7.9%, 5.8%, 7.6%, 7.4%, 7.3%, 8.4%, 7.5%, 7.4%, 8.8%, 8.9%, and 7.6% in each group, respectively. There were no statistically significant differences in clinical pregnancy rates or live birth rates between any groups and those with the post-wash TPMSC <1 × 10 6 . In an IUI program for unexplained and mild male factor infertility, the post-wash TPMSC in the first IUI cycle was not significantly associated with the live birth rate in the second IUI cycle.

摘要:本研究旨在探讨第一个宫内人工授精(IUI)周期洗涤后渐进式活动精子总数(TPMSC)与第二个IUI周期妊娠结局的关系。数据检索自北京大学第三医院生殖中心2011年1月至2022年12月的临床数据库。如果夫妇患有不明原因或轻度男性因素不育,并使用相同的方案连续两个周期进行IUI治疗,则纳入本回顾性队列研究。共有8290对夫妇被纳入分析。女性平均±标准差(sd)年龄为32.0±3.5岁。我们分类组基于post-wash TPMSC(×106)水平在第一IUI循环:组1 (0 < TPMSC < 1, n = 1290),组2(1≤TPMSC < 2 n = 863)组3(2≤TPMSC < 3, n = 800)、组4(3≤TPMSC < 4, n = 783)、组5(4≤TPMSC < 5, n = 1541)、组6(5≤TPMSC < 6 n = 522)组7(6≤TPMSC < 7, n = 547)、组8(7≤TPMSC < 8, n = 175)、组(8≤9 TPMSC < 9 n = 556)、组(9≤10 TPMSC < 10 n = 192)和组11 (TPMSC≥10),n = 1021)。主要观察指标为第二个IUI周期的活产率。各组活产率分别为7.9%、5.8%、7.6%、7.4%、7.3%、8.4%、7.5%、7.4%、8.8%、8.9%、7.6%。在临床妊娠率或活产率方面,任何组与洗后TPMSC组之间都没有统计学上的显著差异
{"title":"Should couples with a low total progressively motile sperm count in the first intrauterine insemination cycle continue this treatment?","authors":"Zheng Wang, Yuan-Yuan Wang, Shuo Huang, Hai-Yan Wang, Rong Li, Ben Willem Mol, Jie Qiao","doi":"10.4103/aja202524","DOIUrl":"10.4103/aja202524","url":null,"abstract":"<p><strong>Abstract: </strong>This study aimed to investigate the associations between the post-wash total progressively motile sperm count (TPMSC) in the first intrauterine insemination (IUI) cycle and pregnancy outcomes of the second IUI cycle. Data were retrieved from the clinical database at the Reproductive Center of Peking University Third Hospital (Beijing, China) between January 2011 and December 2022. Couples were included in this retrospective cohort study if they had unexplained or mild male factor infertility and were treated with IUI for two consecutive cycles using the same protocol. A total of 8290 couples were included in the analysis. The mean ± standard deviation (s.d.) age of women was 32.0 ± 3.5 years. We categorized groups based on the post-wash TPMSC (×10 6 ) levels in the first IUI cycle: group 1 (0 < TPMSC < 1, n = 1290), group 2 (1 ≤ TPMSC < 2, n = 863), group 3 (2 ≤ TPMSC < 3, n = 800), group 4 (3 ≤ TPMSC < 4, n = 783), group 5 (4 ≤ TPMSC < 5, n = 1541), group 6 (5 ≤ TPMSC < 6, n = 522), group 7 (6 ≤ TPMSC < 7, n = 547), group 8 (7 ≤ TPMSC < 8, n = 175), group 9 (8 ≤ TPMSC < 9, n = 556), group 10 (9 ≤ TPMSC < 10, n = 192), and group 11 (TPMSC ≥ 10), n = 1021). The primary outcome was live birth rate of the second IUI cycle. Live birth rates were 7.9%, 5.8%, 7.6%, 7.4%, 7.3%, 8.4%, 7.5%, 7.4%, 8.8%, 8.9%, and 7.6% in each group, respectively. There were no statistically significant differences in clinical pregnancy rates or live birth rates between any groups and those with the post-wash TPMSC <1 × 10 6 . In an IUI program for unexplained and mild male factor infertility, the post-wash TPMSC in the first IUI cycle was not significantly associated with the live birth rate in the second IUI cycle.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"757-762"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144287453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microfluidic systems in testicular in vitro culture: a powerful model tool for spermatogenesis and reprotoxicity studies. 睾丸体外培养中的微流体系统:精子发生和生殖毒性研究的强大模型工具。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-04-22 DOI: 10.4103/aja20254
Botho Maximilian Schneider, Hande Irem Hamurcu, Andrea Salzbrunn, Kathrein von Kopylow

Abstract: As prepubertal boys do not yet produce spermatozoa, they cannot rely on sperm cryopreservation for fertility preservation before gonadotoxic therapy, such as high-dose alkylating agents or radiotherapy in the case of childhood cancers. According to the current guidelines, cryopreservation of testicular biopsies containing spermatogonial stem cells (SSCs) may be proposed to high-risk patients for potential later therapeutic use to fulfill the patients' wish for a biological child. One promising technique for human in vitro spermatogenesis and in vitro propagation of human SSCs is microfluidic (MF) culture, in which cells or tissues are subjected to a continuous flow of medium. This provides exact control over such parameters as nutrient content and gradients, as well as the removal of waste metabolites. While MF has been shown to maintain tissues and cell populations of organs for longer than conventional in vitro culture techniques, it has not been widely used for testicular in vitro culture. MF could advance human testicular in vitro culture and is also applicable to reprotoxicity studies. This review summarizes the findings and achievements of testis-on-chip (ToC) setups to date and discusses the benefits and limitations of these for spermatogenesis in vitro and toxicity assessment.

摘要:由于青春期前的男孩尚未产生精子,在儿童癌症的促性腺毒性治疗(如大剂量烷基化剂或放疗)前,他们不能依靠精子冷冻保存来保存生育能力。根据目前的指南,含有精原干细胞(SSCs)的睾丸活组织冷冻保存可能会被推荐给高风险患者,用于潜在的后期治疗用途,以满足患者对生物学孩子的愿望。微流控(MF)培养是人类体外精子发生和人类ssc体外繁殖的一种很有前途的技术,在这种技术中,细胞或组织受到连续流动的培养基的影响。这提供了对诸如养分含量和梯度等参数的精确控制,以及废物代谢物的去除。虽然MF已被证明比传统的体外培养技术维持器官组织和细胞群的时间更长,但它尚未广泛用于睾丸体外培养。MF可促进人睾丸体外培养,也可用于生殖毒性研究。本文综述了迄今为止芯片睾丸(ToC)装置的发现和成就,并讨论了这些装置在体外精子发生和毒性评估方面的优点和局限性。
{"title":"Microfluidic systems in testicular in vitro culture: a powerful model tool for spermatogenesis and reprotoxicity studies.","authors":"Botho Maximilian Schneider, Hande Irem Hamurcu, Andrea Salzbrunn, Kathrein von Kopylow","doi":"10.4103/aja20254","DOIUrl":"10.4103/aja20254","url":null,"abstract":"<p><strong>Abstract: </strong>As prepubertal boys do not yet produce spermatozoa, they cannot rely on sperm cryopreservation for fertility preservation before gonadotoxic therapy, such as high-dose alkylating agents or radiotherapy in the case of childhood cancers. According to the current guidelines, cryopreservation of testicular biopsies containing spermatogonial stem cells (SSCs) may be proposed to high-risk patients for potential later therapeutic use to fulfill the patients' wish for a biological child. One promising technique for human in vitro spermatogenesis and in vitro propagation of human SSCs is microfluidic (MF) culture, in which cells or tissues are subjected to a continuous flow of medium. This provides exact control over such parameters as nutrient content and gradients, as well as the removal of waste metabolites. While MF has been shown to maintain tissues and cell populations of organs for longer than conventional in vitro culture techniques, it has not been widely used for testicular in vitro culture. MF could advance human testicular in vitro culture and is also applicable to reprotoxicity studies. This review summarizes the findings and achievements of testis-on-chip (ToC) setups to date and discusses the benefits and limitations of these for spermatogenesis in vitro and toxicity assessment.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"659-668"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation. CFAP300功能缺失变体通过破坏精子鞭毛组装和顶体形成导致原发性纤毛运动障碍和男性不育。
IF 2.7 Pub Date : 2025-11-01 Epub Date: 2025-09-02 DOI: 10.4103/aja202556
Hua-Yan Yin, Yu-Qi Zhou, Qun-Shan Shen, Zi-Wen Chen, Jie-Ru Li, Huan Wu, Yun-Xia Cao, Rui Guo, Bing Song

Abstract: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by impaired motility of cilia and flagella. Mutations in cilia- and flagella-associated protein 300 ( CFAP300 ) are associated with human PCD and male infertility; however, the underlying pathogenic mechanisms remain poorly understood. In a consanguineous Chinese family, we identified a homozygous CFAP300 loss-of-function variant (c.304delC) in a proband presenting with classical PCD symptoms and severe sperm abnormalities, including dynein arm deficiency and acrosomal malformation, as confirmed by transmission electron microscopy (TEM). Histological analysis revealed multiple morphological abnormalities of the sperm flagella in CFAP300 -mutant individual, whereas immunofluorescence demonstrated markedly reduced CFAP300 expression in the spermatozoa of the proband. Furthermore, tandem mass tag (TMT)-based quantitative proteomics showed that the CFAP300 mutation reduced key spermatogenesis proteins (e.g., sperm flagellar 2 [SPEF2], solute carrier family 25 member 31 [SLC25A31], and A-kinase anchoring protein 3 [AKAP3]) and mitochondrial ATP synthesis factors (e.g., SLC25A31, cation channel sperm-associated 3 [CATSPER3]). It also triggered abnormal increases in autophagy-related proteins and signaling mediator phosphorylation. These molecular alterations are likely to contribute to progressive deterioration of sperm ultrastructure and function. Notably, successful pregnancy was achieved via intracytoplasmic sperm injection (ICSI) using the proband's sperm. Overall, this study expands the known CFAP300 mutational spectrum and offers novel mechanistic insights into its role in spermatogenesis.

原发性纤毛运动障碍(PCD)是一种以纤毛和鞭毛运动障碍为特征的遗传异质性疾病。纤毛和鞭毛相关蛋白300 (CFAP300)突变与人类PCD和男性不育有关;然而,潜在的致病机制仍然知之甚少。在一个中国近亲家庭中,通过透射电子显微镜(TEM),我们在一名先证患者身上发现了CFAP300纯合子功能缺失变异(c.304delC),该患者表现出典型的PCD症状和严重的精子异常,包括动力蛋白臂缺乏和顶体畸形。组织学分析显示,CFAP300突变个体的精子鞭毛存在多种形态异常,而免疫荧光显示CFAP300在先显子精子中的表达明显降低。此外,基于串联质量标签(TMT)的定量蛋白质组学研究表明,CFAP300突变减少了关键的精子发生蛋白(如精子鞭毛2 [SPEF2]、溶质载体家族25成员31 [SLC25A31]和a激酶锚定蛋白3 [AKAP3])和线粒体ATP合成因子(如SLC25A31、阳离子通道精子相关3 [CATSPER3])。它还引发了自噬相关蛋白和信号介质磷酸化的异常增加。这些分子改变可能导致精子超微结构和功能的进行性恶化。值得注意的是,通过使用先证者的精子进行卵胞浆内单精子注射(ICSI)成功怀孕。总的来说,这项研究扩展了已知的CFAP300突变谱,并为其在精子发生中的作用提供了新的机制见解。
{"title":"CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation.","authors":"Hua-Yan Yin, Yu-Qi Zhou, Qun-Shan Shen, Zi-Wen Chen, Jie-Ru Li, Huan Wu, Yun-Xia Cao, Rui Guo, Bing Song","doi":"10.4103/aja202556","DOIUrl":"10.4103/aja202556","url":null,"abstract":"<p><strong>Abstract: </strong>Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by impaired motility of cilia and flagella. Mutations in cilia- and flagella-associated protein 300 ( CFAP300 ) are associated with human PCD and male infertility; however, the underlying pathogenic mechanisms remain poorly understood. In a consanguineous Chinese family, we identified a homozygous CFAP300 loss-of-function variant (c.304delC) in a proband presenting with classical PCD symptoms and severe sperm abnormalities, including dynein arm deficiency and acrosomal malformation, as confirmed by transmission electron microscopy (TEM). Histological analysis revealed multiple morphological abnormalities of the sperm flagella in CFAP300 -mutant individual, whereas immunofluorescence demonstrated markedly reduced CFAP300 expression in the spermatozoa of the proband. Furthermore, tandem mass tag (TMT)-based quantitative proteomics showed that the CFAP300 mutation reduced key spermatogenesis proteins (e.g., sperm flagellar 2 [SPEF2], solute carrier family 25 member 31 [SLC25A31], and A-kinase anchoring protein 3 [AKAP3]) and mitochondrial ATP synthesis factors (e.g., SLC25A31, cation channel sperm-associated 3 [CATSPER3]). It also triggered abnormal increases in autophagy-related proteins and signaling mediator phosphorylation. These molecular alterations are likely to contribute to progressive deterioration of sperm ultrastructure and function. Notably, successful pregnancy was achieved via intracytoplasmic sperm injection (ICSI) using the proband's sperm. Overall, this study expands the known CFAP300 mutational spectrum and offers novel mechanistic insights into its role in spermatogenesis.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"743-750"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144982260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian journal of andrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1